Patients and carers

  • Email
  • Help

Information for you

On this page, you will find information on the Agency’s activities that are most relevant to patients and carers, including news, and events.

You can contribute to the Agency’s work by responding to public consultations.

Learn more about how Patients and carers are actively involved in the work of the Agency.

Featured information

  • human newsletter

    Newsletter - Human medicines highlights

    This newsletter is addressed primarily to organisations representing patients, consumers and healthcare professionals. It provides a summary of key information relating to medicines for human use published by disease area during the previous month by the European Medicines Agency (EMA).

  • Patients at the heart of future innovation

    On 18 March 2015 EMA marked its 20th anniversary with a scientific conference entitled 'Science, Medicines, Health: Patients at the heart of future innovation'.

    Yann Le Cam (Chief Executive Officer, EURORDIS) was invited to represent the patients’ perspective on a panel discussion. Watch the video recording.

  • Preventing medication errors for high-strength/fixed-combination insulins

    The Pharmacovigilance Risk Assessment Committee (PRAC) raised concerns about a potential risk of medication errors following recent approval of high-strength insulins (higher than the EU-wide standard 100 units/ml concentration). The PRAC developed guidance that provides a strategy to proactively address this risk in a harmonised way across the EU. Patients were extensively consulted for input based on their practical experience. The draft guidance has been released for public consultation.

  • Beware of falsified medicines!

    Falsified medicines are fake medicines that may enter the supply chain illegally. Be careful about the way you buy medicines. For internet sales, there will be a logo to identify authorised online pharmacies and approved retailers providing authentic, authorised medicines. Read more about falsified medicines.

News for patients and carers

Events of interest

  • 28/05/2015 - 29/05/2015


    Annual workshop of the European network of paediatric research at the European Medicines Agency

    Day one of the workshop, 28 May, is an open meeting to all stakeholders: patient/parent organisations, network representatives, pharmaceutical industry staff responsible for paediatric studies and regulators. Day two, 29 May is dedicated to members of Enpr-EMA and its Coordinating Group. Registration is open until 15 May 2015 using the registration form. ... Read more

  • 18/03/2015


    Science, Medicines, Health: Patients at the heart of future innovation conference

    The invitation-only conference is organised to celebrate the 20th anniversary of the European Medicines Agency. Looking back at the past two decades, the Agency is proud of its successes, impressive growth and achievements. Yet, in addition to celebrating past successes, the Agency has its eyes firmly set in the challenges of the future. Cognisant of its pivotal role at the crossroads of life science research and development, patient care, public health policy and law, the Agency will use this event to explore with a range of stakeholders how best to deliver its role in the future. ... Read more

  • 17/03/2015


    Collaboration on neonatal issues between researchers and the European Medicines Agency

    The aim of the meeting is to develop ways to work together that optimise the design and conduct of neonatal medicines research in Europe. During this meeting we will share perspectives about the current state of neonatal medicines research in Europe, review “hot topics” and prioritise them, and develop an action plan for 2015. Registration by invitation only. ... Read more

  • 19/02/2015 - 20/02/2015


    PROTECT symposium

    The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) is a five-year public-private partnership of 34 partners, which was initiated in 2009 to enhance the monitoring of the safety of medicinal products and contribute to better evaluate and communicate their benefit-risk profile throughout their lifecycle. To this end, PROTECT planned to develop and test methodological standards and innovative tools. The objective of this final PROTECT symposium is to present the main results and recommendations of PROTECT and discuss their implications from a methodological perspective and for the evaluation of the benefits and risks of medicines. Four parallel pre-symposium training courses provide in-depth training on specific aspects of the research work performed in PROTECT. Registration closed. ... Read more

  • 04/12/2014 - 05/12/2014


    European Medicines Agency/European Federation of Pharmaceutical Industries and Associations workshop on the importance of dose finding and dose selection for the successful development, licensing and lifecycle management of medicinal products

    EMA/EFPIA workshop is planned for 4-5 December 2014 to discuss the importance of dose finding and dose selection for the successful development, licensing and lifecycle management of medicinal products. Registration: please register by 19 September 2014 using the registration form provided. ... Read more

  • See all Events of interest

Information for:

Find information for...

Medicines for elderly

ADR website spotlight

FAQ spotlight